海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
- Metastatic Prostate Cancer
- Belgium, Brazil, France, Korea, Republic of, Netherlands, United States
- 2019-03-11
Not recruiting
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Belarus, Brazil, Canada, China, Czech Republic, Czechia, Denmark, Finland, France, Germany, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United States
- 2011-03-03
Not recruiting
- Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Venezuela
- 2005-10-09
Not recruiting
- Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Israel, Italy, Korea, Republic of, Peru, Poland, Portugal, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2008-05-08
Not recruiting
- XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer
- Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms;Neoplasms;Prostatic Neoplasms
- Argentina, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States, Uruguay
- 2006-12-28
Not recruiting
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
- Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2003-03-11
Not recruiting
- Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2008-08-29
Not recruiting
- Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule
- Prostate Cancer
- Brazil
- 2014-09-29
Not Recruiting
- AFFIRM: A Multinational Phase 3, Randomized, Double-Blind, Placebo-COntrolled Efficacy and Safety Study of Oral MDV3100 in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Castration-Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Canada, Chile, France, Germany, Italy, Netherlands, Poland, South Africa, Spain, United Kingdom, United States
- 2014-04-14
Not Recruiting
- A Three Arm Randomized, Open-label Phase II Study of Radium-223 Dichloride 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) Versus 80 kBq/kg (88 kBq/kg After Implementation of NIST Update), and Versus 50 kBq/kg (55 kBq/kg After Implementation of NIST Update) in an Extended Dosing Schedule in Subjects With Castration-resistant Prostate Cancer Metastatic to the Bone
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Australia, Brazil, Canada, Chile, Czech Republic, Finland, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Sweden, Taiwan, Province of China, United Kingdom, United States
- 2015-06-25
